Utilization of Biologic Disease-Modifying Antirheumatic Therapy in Patients With Rheumatoid Arthritis and Recently Diagnosed Breast Cancer.

Juan Ignacio RuizXiudong LeiChi-Fang WuHui ZhaoSharon H GiordanoSuja S RajanMaria E Suarez-Almazor

Published in: Arthritis care & research (2024)

The utilization of tumor necrosis factor inhibitors and other bDMARDs in patients with RA and recent BC has not increased since 2008. Glucocorticoids utilization remained high. The largest predictor of bDMARD utilization was prior use before BC.

Keyphrases

rheumatoid arthritis
disease activity
mesenchymal stem cells
systemic sclerosis
rheumatoid arthritis patients
interstitial lung disease
bone marrow
cell therapy